# Vaccine: X


**Publisher**: Elsevier
**Country**: United Kingdom
**ISSN**: 2590-1362
**Official Website**: [https://www.journals.elsevier.com/vaccine-x](https://www.journals.elsevier.com/vaccine-x)
**DOAJ Listing**: [https://doaj.org/toc/2590-1362](https://doaj.org/toc/2590-1362)

---

## 📊 Key Impact Metrics & Scholarly Profile
- **Trust / Quality Score**: 68/100
- **h-Index**: 33
- **i10-Index**: 183 (Articles with ≥ 10 citations)
- **2-Year Mean Citedness**: 2.51
- **Global Citations**: 5,976
- **Published Works / Articles**: 864
- **Active Publication Years**: 1956 – 2026


---

## 🔓 Access, Licensing & Editorial Speed
- **Access Model**: Open Access
- **License**: CC BY ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/))- **Publication Turnaround Time**: 13 weeks (average review to publication)
- **Author Retains Copyright**: No / Transferred
- **APC Waiver Policy**: Available (for eligible authors/regions)
- **Article Processing Charge (APC)**: 2,440 USD

---

## 🛡️ Indexing & Verification Status
- **Open Access Status**: ✅ Open Access Verified
- **Core Academic Source**: —
- **Open Journal Systems (OJS)**: —
- **Registered Indexing Partners**:
  - OpenAlex (Verified)
  - Crossref (Verified)
  - DOAJ (Verified)

---

## 📑 Official Editorial & Policy Links
- **Author Guidelines**: [https://www.elsevier.com/journals/vaccine-x/2590-1362/guide-for-authors](https://www.elsevier.com/journals/vaccine-x/2590-1362/guide-for-authors)
- **Aims & Scope**: [https://www.journals.elsevier.com/vaccine-x](https://www.journals.elsevier.com/vaccine-x)
- **Editorial Board**: [https://www.journals.elsevier.com/vaccine-x/editorial-board](https://www.journals.elsevier.com/vaccine-x/editorial-board)
- **Peer Review Process**: [https://www.elsevier.com/journals/vaccine-x/2590-1362/guide-for-authors](https://www.elsevier.com/journals/vaccine-x/2590-1362/guide-for-authors)
- **Open Access Statement**: [https://www.elsevier.com/journals/vaccine-x/2590-1362/open-access-journal](https://www.elsevier.com/journals/vaccine-x/2590-1362/open-access-journal)
- **Publication Ethics**: [https://www.elsevier.com/journals/vaccine-x/2590-1362/guide-for-authors](https://www.elsevier.com/journals/vaccine-x/2590-1362/guide-for-authors)
- **APC / Charges**: [https://www.sciencedirect.com/journal/vaccine-x/publish/open-access-options](https://www.sciencedirect.com/journal/vaccine-x/publish/open-access-options)
- **Copyright & Licensing Terms**: [https://www.sciencedirect.com/journal/vaccine-x/publish/open-access-options](https://www.sciencedirect.com/journal/vaccine-x/publish/open-access-options)

---


## ❓ Frequently Asked Questions
### Is Vaccine: X indexed in DOAJ?
Vaccine: X is listed in DOAJ (Directory of Open Access Journals). You can verify its open-access licensing and peer-review policies via its DOAJ entry.

### What is the ISSN for Vaccine: X?
Print ISSN: 2590-1362. 

### Who publishes Vaccine: X?
Vaccine: X is published by Elsevier.

### Does Vaccine: X charge Article Processing Charges (APC)?
Vaccine: X has an APC fee of 2,440 USD.


---

## 🧭 Agent Instructions & Citation
- **APA Citation**: `Vaccine: X. (2026). Elsevier, ISSN 2590-1362. CallForPaper.org. https://callforpaper.org/journal/vaccine-x`
- **Standard HTML URL**: `https://callforpaper.org/journal/vaccine-x`
- **Markdown URL**: `https://callforpaper.org/journal/vaccine-x.md`